Supreme Court restores access to abortion pill mifepristone, for now

For now, patients can still get mifepristone through telehealth visits and mail delivery under the Food and Drug Administration’s current rules, after the Supreme Court temporarily blocked a lower-court ruling that threatened to upend a major route to abortion care across the United States.

That immediate relief matters because mifepristone is not a niche drug. First approved by the FDA in 2000, it is part of the two-drug medication abortion regimen used in nearly two-thirds of U.S. abortions in recent years. Preserving access through telehealth and pharmacies, alongside mail-order fulfillment, kept in place a system that has expanded reach for patients who live far from clinics, cannot easily take time off work, or face other barriers that turn geography and income into medical risk.

The underlying case, FDA v. Alliance for Hippocratic Medicine, grew out of a challenge by anti-abortion doctors and medical associations to the FDA’s approval of mifepristone and later regulatory changes in 2016 and 2021. Those changes made it easier to prescribe the drug remotely and receive it without an in-person visit, a shift that advocates say broadened access while opponents argued it weakened safeguards and should be rolled back.

The legal fight has already moved through one round at the Supreme Court. Justices heard oral arguments on March 26, 2024, and on June 13, 2024, the Court ruled on standing grounds rather than reaching the merits, leaving FDA approval intact. Even so, the new temporary order underscored how fragile the status quo remains. A different lower-court ruling could have quickly altered access for patients and providers before the justices weigh in again.

Planned Parenthood said access remained unchanged for now, but warned the fight was not over. That is the central reality of medication abortion in 2026: the practical rules that shape care can change fast, and each legal turn lands first on patients who need a prescription, a pharmacy, or a package in the mail. The Supreme Court’s temporary move preserved access for the moment, but it did not resolve the national battle over abortion pills.